Tokyo Tape
Sign in
← AFC-HD AMS Life Science

Quarterly report · Q2

2927.TEDINET S100QLNK
Period2022-09-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥12.4bn2022-09-01 → 2023-02-28Cons.Net sales
Revenue¥23.0bn2021-09-01 → 2022-08-31Cons.Net sales (5-year summary)
Revenue¥11.2bn2021-09-01 → 2022-02-28Cons.Net sales
Operating income¥678m2022-09-01 → 2023-02-28Cons.Operating income
Operating income¥453m2021-09-01 → 2022-02-28Cons.Operating income
Ordinary income¥708m2022-09-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥1.3bn2021-09-01 → 2022-08-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥643m2021-09-01 → 2022-02-28Cons.Ordinary income
Profit before tax¥616m2022-09-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥560m2021-09-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)¥414m2022-09-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥735m2021-09-01 → 2022-08-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥307m2021-09-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income¥417m2022-09-01 → 2023-02-28Cons.Profit loss
Net income¥307m2021-09-01 → 2022-02-28Cons.Profit loss
Total assets¥39.0bnat 2023-02-28Cons.Assets
Total assets¥37.3bnat 2022-08-31Cons.Assets
Total assets¥35.9bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥26.3bnat 2023-02-28Cons.Liabilities
Total liabilities¥24.9bnat 2022-08-31Cons.Liabilities
Net assets / equity¥12.6bnat 2023-02-28Cons.Net assets
Net assets / equity¥12.4bnat 2022-08-31Cons.Net assets
Net assets / equity¥12.7bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥10.9bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥10.4bnat 2022-08-31Cons.Cash and deposits
Cash & equivalents¥10.8bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥10.3bnat 2022-08-31Cons.Cash and cash equivalents
Cash & equivalents¥8.6bnat 2022-02-28Cons.Cash and cash equivalents
Cash & equivalents¥8.7bnat 2021-08-31dCons.Cash and cash equivalents
Operating cash flow¥397m2022-09-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥1.5bn2021-09-01 → 2022-08-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥314m2021-09-01 → 2022-02-28Cons.Net cash provided by used in operating activities
Investing cash flow−¥791m2022-09-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.1bn2021-09-01 → 2022-08-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.2bn2021-09-01 → 2022-02-28Cons.Net cash provided by used in investment activities
Financing cash flow¥924m2022-09-01 → 2023-02-28Cons.Net cash provided by used in financing activities
Financing cash flow¥1.2bn2021-09-01 → 2022-08-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥774m2021-09-01 → 2022-02-28Cons.Net cash provided by used in financing activities
EPS (basic)¥29.462022-09-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.012022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.332021-09-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.842021-09-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.82021-12-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.452022-09-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥52.082021-09-01 → 2022-08-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥21.712021-09-01 → 2022-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio32.3%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio33.2%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Otherother segmentsrevenue2022-09-01 → 2023-02-28¥540m
Otherother segmentsrevenue external2022-09-01 → 2023-02-28¥540m
Otherother segmentssegment profit2022-09-01 → 2023-02-28−¥2m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue2022-09-01 → 2023-02-28¥2.8bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue external2022-09-01 → 2023-02-28¥2.8bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentsegment profit2022-09-01 → 2023-02-28¥13m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue2022-09-01 → 2023-02-28¥698m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue external2022-09-01 → 2023-02-28¥698m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentsegment profit2022-09-01 → 2023-02-28−¥121m
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue2022-09-01 → 2023-02-28¥7.3bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue external2022-09-01 → 2023-02-28¥7.3bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentsegment profit2022-09-01 → 2023-02-28¥940m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue2022-09-01 → 2023-02-28¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue external2022-09-01 → 2023-02-28¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentsegment profit2022-09-01 → 2023-02-28¥103m
Total Of Reportable Segments And Otherssegment totalrevenue2022-09-01 → 2023-02-28¥12.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-09-01 → 2023-02-28¥12.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-09-01 → 2023-02-28¥933m
Otherother segmentsrevenue2021-09-01 → 2022-02-28¥23m
Otherother segmentsrevenue external2021-09-01 → 2022-02-28¥23m
Otherother segmentssegment profit2021-09-01 → 2022-02-28−¥10m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue2021-09-01 → 2022-02-28¥2.3bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue external2021-09-01 → 2022-02-28¥2.3bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentsegment profit2021-09-01 → 2022-02-28−¥122m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue2021-09-01 → 2022-02-28¥441m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue external2021-09-01 → 2022-02-28¥441m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentsegment profit2021-09-01 → 2022-02-28−¥190m
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue2021-09-01 → 2022-02-28¥7.6bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue external2021-09-01 → 2022-02-28¥7.6bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentsegment profit2021-09-01 → 2022-02-28¥992m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue2021-09-01 → 2022-02-28¥871m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue external2021-09-01 → 2022-02-28¥871m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentsegment profit2021-09-01 → 2022-02-28¥85m
Total Of Reportable Segments And Otherssegment totalrevenue2021-09-01 → 2022-02-28¥11.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-09-01 → 2022-02-28¥11.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-09-01 → 2022-02-28¥755m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 536
ItemContextValueUnit
Other nclPrior1YearInstant547245000JPY
Other nclCurrentQuarterInstant524619000JPY
Noncurrent liabilitiesPrior1YearInstant11684762000JPY
Noncurrent liabilitiesCurrentQuarterInstant11575052000JPY
LiabilitiesPrior1YearInstant24903511000JPY
LiabilitiesCurrentQuarterInstant26308055000JPY
Capital stockPrior1YearInstant2131839000JPY
Capital stockCurrentQuarterInstant2131839000JPY
Capital surplusPrior1YearInstant2640231000JPY
Capital surplusCurrentQuarterInstant2632282000JPY
Retained earningsPrior1YearInstant7880483000JPY
Retained earningsCurrentQuarterInstant8084011000JPY
Treasury stockPrior1YearInstant-305391000JPY
Treasury stockCurrentQuarterInstant-273777000JPY
Shareholders equityPrior1YearInstant12347163000JPY
Shareholders equityCurrentQuarterInstant12574355000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-808000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-38107000JPY
Foreign currency translation adjustmentPrior1YearInstant25907000JPY
Foreign currency translation adjustmentCurrentQuarterInstant23827000JPY
Remeasurements of defined benefit plansPrior1YearInstant42259000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant39961000JPY
Valuation and translation adjustmentsPrior1YearInstant67358000JPY
Valuation and translation adjustmentsCurrentQuarterInstant25680000JPY
Subscription rights to sharesPrior1YearInstant24568000JPY
Subscription rights to sharesCurrentQuarterInstant－JPY
Non controlling interestsPrior1YearInstant6058000JPY
Non controlling interestsCurrentQuarterInstant44922000JPY
Net assetsPrior1YearInstant12445149000JPY
Net assetsCurrentQuarterInstant12644959000JPY
Liabilities and net assetsPrior1YearInstant37348660000JPY
Liabilities and net assetsCurrentQuarterInstant38953015000JPY
Net salesPrior1YTDDuration11202916000JPY
Net salesCurrentYTDDuration12444800000JPY
Cost of salesPrior1YTDDuration6947986000JPY
Cost of salesCurrentYTDDuration7773291000JPY
Gross profitPrior1YTDDuration4254930000JPY
Gross profitCurrentYTDDuration4671508000JPY
Selling general and administrative expensesPrior1YTDDuration3801826000JPY
Selling general and administrative expensesCurrentYTDDuration3993212000JPY
Operating incomePrior1YTDDuration453103000JPY
Operating incomeCurrentYTDDuration678295000JPY
Interest income noiPrior1YTDDuration1848000JPY
Interest income noiCurrentYTDDuration2022000JPY
Dividends income noiPrior1YTDDuration5365000JPY
Dividends income noiCurrentYTDDuration5892000JPY
Gain on sales of investment securities noiPrior1YTDDuration2768000JPY
Gain on sales of investment securities noiCurrentYTDDuration17478000JPY
Subsidy income noi bountyPrior1YTDDuration195795000JPY
Subsidy income noi bountyCurrentYTDDuration15262000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-08-31pass
balance sheet identityconsolidated 2023-02-28pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-09-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-09-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2021-09-01/2022-02-28pass
statement vs summary · operating cash flowconsolidated 2022-09-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-09-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-09-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-08-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass